MRC1 and Lynch syndrome: Eighteen of the patients (24.4%) presented a Lynch syndrome, as defined by the presence of a deleterious germline MMR mutation (16 patients) or a presentation fulfilling Amsterdam criteria in patients without germline MMR mutation (2 patients).